Kyle Newton

Kyle Newton is currently the Associate Director of mRNA Based Cancer Immunotherapy Systems at BioNTech and previously held the role of Associate Director and Cell Therapy Digital Product Manager at Bristol Myers Squibb. With a background in business consultancy and project management across various leading firms, Kyle has been instrumental in developing innovative digital solutions that enhance cell therapy logistics and improve user experiences. Prior experience includes significant contributions at Juno Therapeutics and AbbVie, where they played key roles in technology adoption and process improvement. Kyle holds a degree from Purdue University, where they continue their education.